Obituary
Dennis Haskins, 'Saved by the Bell' Principal, Dies at 75
Actor Dennis Haskins, best known for his role as Principal Richard Belding on the hit sitcom 'Saved by the Bell,' has passed away at the age of 75.
Reported by 3 sources
Section
Updated 1:35 AM EDT
Obituary
Actor Dennis Haskins, best known for his role as Principal Richard Belding on the hit sitcom 'Saved by the Bell,' has passed away at the age of 75.
Reported by 3 sources
Culture
Reported by 2 sources
Culture
Reported by 3 sources
Culture
New research reveals that a cluster of sixteen major flooding events struck Central Europe between 1341 and 1343, reshaping infrastructure practices and offering insights into how successive disasters compound risk.
Reported by 1 source
Culture
Produced for just $750,000, the film has achieved significant commercial success and critical acclaim, challenging industry norms for horror releases.
Reported by 4 sources
Culture
Christopher Nolan's adaptation of the classic epic is scheduled for digital and physical release, while fans analyze filming locations to understand the film's visual scope.
Reported by 3 sources
Culture
The singer-songwriter dropped the track as a limited-edition CD single at an indie record store, drawing attention for its thematic ties to Margaret Atwood’s dystopian novel.
Reported by 4 sources
Culture
The actor and former wrestler received the prestigious award from Emily Blunt, joking about the new perks for his children.
Reported by 3 sources
Culture
The veteran actress posted images from the French Riviera alongside friends, drawing attention to her continued public presence at age 93.
Reported by 2 sources
Culture
The former presenter has broken his silence on the show's new lineup, urging fans to give the replacements a chance as production seeks continuity.
Reported by 3 sources
Culture
Reviews for 'Insidious: Out of the Further' suggest diminishing returns for the horror series, with critics debating whether the franchise has exhausted its creative potential.
Reported by 2 sources
Culture
The author's recent comments have surprised critics and supporters alike, marking a shift in tone amid ongoing debates about her previous views.
Reported by 4 sources
Culture
Moderna and Merck report that a custom-made vaccine, combined with standard immunotherapy, significantly delayed cancer return in late-stage trials, marking a potential shift toward individualized oncology treatments.
Reported by 1 source
The News Journal standard
Homepage stories must describe one coherent event and pass a separate sourcing review before publication.
The 7-minute briefing
A concise guide to the stories shaping the day, sent each morning.